Abstract
Welfare systems are designed on geographical and membership boundaries. In terms of access to health care this implies that, as a general rule, only individuals residing in their national territory can obtain health care from providers located there. However, in the past few years medical tourism has grown at an explosive pace throughout the world and in Europe. Each year in fact a small, but significant number of European citizens seek medical treatment that is financed by their public insurer in another EU country. From an economic point of view, it is important to distinguish between the two following sources of patients’ mobility: a regulated mobility, where the third payer decides to send patients abroad and patients’ choice, where the patient himself decides to seek care abroad. In this article we show how the combined effect of restrictions to the use of health care, transfer prices, and mobility rules determine social welfare and its allocation between Regions. The results are quite interesting: if the price set for these patients is equal to the marginal cost of the more efficient Region, patients’ mobility should be preferred to patients’ choice. On the other hand, if the price is equal to the marginal cost of the less efficient Region, patient choice should be preferred. The other interesting result is a possible trade off between a static model where each Region chooses its level of cost/effectiveness and a more long term situation, where patient mobility determines a common level for this parameter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Estimates vary from half to two million patients. See Alleman et al. (2011) for a review.
- 2.
- 3.
The effectiveness of the treatment can vary for several reasons, for example an active principle that reduces blood pressure might be less effective when used for treating patients with multiple diseases.
- 4.
- 5.
For a discussion on the implications of integration on the health of Europeans see Mackenbach et al. (2013) and references therein.
References
Alleman, B. W., Luger, T., Schacht Reisinger, H., Martin, R., Horowitz, M. D., & Cram, P. (2011). Medical tourism services available to residents of the United States. Journal of General Internal Medicine, 26(5), 492–497.
Brekke, K. R., Cellini, R., Siciliani, L., & Straume, O. R. (2012). Competition in regulated markets with sluggish beliefs about quality. Journal of Economics and Management Strategy, 21(1), 131–178.
Brekke, K. R., Gravelle, H., Siciliani, L., & Straume, O. R. (2014). Patient choice, mobility and competition among health care providers. In R. Levaggi & M. Montefiori (Ed.), Health care provision and patient mobility: Health integration in the European Union. Italia: Springer-Verlag.
Brekke, K. R., Levaggi, R., Siciliani, L., & Straume, O. R. (2011). Patient mobility, health care quality and welfare. CEPR Discussion Papers 8559, C.E.P.R. Discussion Papers.
Burge, P., Devlin, N., Appleby, J., Rohr, C., & Grant, J. (2004). Do patients always prefer quicker treatment? A discrete choice analysis of patients’ stated preferences in the London patient choice project. Applied Health Economics and Health Policy, 3(4), 183–194.
Glinos, I., Baeten, R., & Boffin, N. (2006). Cross-border contracted care in Belgian hospitals, in patient mobility in the European Union: Learning from experience. European Observatory on Health Systems and Policies, Copenhagen, pp. 97–118.
Glinos, I. A., Baeten, R., & Maarse, H. (2010). Purchasing health services abroad: Practices of cross-border contracting and patient mobility in six European countries. Health Policy, 95(2–3), 103–112.
Greer, S. L., Hervey, T. K., Mackenbach, J. P., & McKee, M. (2013). Health law and policy in the European Union. The Lancet, 381(9872), 1135–1144.
Legido-Quigley, H., Glinos, I., Baeten, R., & McKee, M. (2007). Patient mobility in the European Union. British Medical Journal 334(7586), 188–190.
Levaggi, R., & Menoncin, F. (2011). Decentralisation in the provision of merit and impure public goods: Who gains, who loses. SSRN eLibrary.
Mackenbach, J. P., Karanikolos, M., & McKee, M. (2013). The unequal health of Europeans: Successes and failures of policies. Lancet, 381(9872), 1125–1134.
Mainil, T., Van Loon, F., Dinnie, K., Botterill, D., Platenkamp, V., & Meulemans, H. (2012). Transnational health care: From a global terminology towards transnational health region development. Health Policy, 108(1), 37–44.
Santuari, A. (2013). The European Union Directive on the application of patients’ right in cross-border health care. Journal of Public Health Research, 2(1).
Wagner, C., & Linder, R. (2010). The demand for EU cross-border care: An empirical analysis. Journal of Management and Marketing in Healthcare, 3(2), 176–187.
Wildasin, D. E. (2001). Externalities and bailouts: hard and soft budget constraints in intergovernmental fiscal relations. Public Economics 0112002, EconWPA.
Wildasin, D. E. (2004). The institutions of federalism: Towards an analytical framework. National Tax Journal, LVII, 247–272.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Appendix
Appendix
1.1 Derivation of the Optimal Quantities
-
1.
No Mobility
The optimal quality \( q_{j,/;NM} \) is derived from the maximization of (5) over \( q_{j} \). The F.O.C. gives the condition: \( - \theta_{j} {\kern 1pt} q_{j} + \frac{1}{2}\left( {1 - c_{j} } \right) = 0 \), which gives the result in (6).
-
2.
Regulated mobility
In this case for Region 0 the welfare in (10) has to be maximized for \( r \) and \( q_{0} \). The function is strictly increasing in the first variable, while the derivative with respect to the second one is the same as for the NM case. Then Region 0 will accept any number of patients as long as \( p \ge v_{0} \) without changing the offered quality.
For Region 1 the welfare function changes and can be written as in (12) and the maximization is done on \( r \) and \( q_{1} \). The F.O.C. gives the following conditions:
The solutions of the above linear system are reported in (14) and (15). In order for them to be feasible the condition \( \frac{1}{2} < r_{RM} < 1 \) has to be satisfied. This implies that the following condition has to be verified
From the second inequality we get
and since \( q_{0,NM} + v_{1} - p > q_{1,NM} \) this is possible only if \( 1 - c_{1} - 2{\kern 1pt} m{\kern 1pt} \theta_{1} < 0 \), which further entails the condition \( q_{0,NM} - m + v_{1} - p < 0 \). The given optimal value for \( r \) is then feasible only if
-
3.
Patient choice
Region 0 maximizes (19) over \( q_{0} \); the F.O.C. in this case is
which does not depend on the quality chosen in Region 1 and gives the optimal quality \( q_{0,PC} \) given in (20).
Region 1 maximizes (21) over \( q_{1} \); the F.O.C. is
and the optimal quality is thus given by (22).
The number of moving patients is given by
which is greater than \( \frac{1}{2} \) because \( q_{0,PC} \ge q_{0,NM} > q_{1,\;NM} > q_{1,PC} \) and under (13) is also less than 1. In fact \( z < 1 \) iff \( q_{0,PC} - q_{1,PC} < m \) and substituting in the inequalities the values in (20) and (22) the condition is equivalent to require that
The ensuing condition
is always verified under hypothesis (13) because
and since \( \theta_{0} < \theta_{1} \) the right-hand side is greater than the lower bound in (27).
1.2 Welfare Analysis for the Patient Choice Case
The welfare difference between the PC and the RM case is given in Eq. (25) and by substitution of the optimal values \( q_{0,PC} \), \( q_{1,PC} \) and \( r_{RM} \) it can be written as
The term outside the square bracket is positive and by algebraic tools it is easy to show that the term multiplying \( p \) inside the square bracket is positive for \( \theta_{0} < \theta_{1} \). Thus the welfare difference is positive whenever \( p \) is greater than the bound in (26).
For Region 1 the best way to proceed is to analyze the behavior wrt \( p \) of the two optimal welfare levels \( W_{1,PC} \) and \( W_{1,RM} \) obtained by substitution of the optimal quantities in (21) and (12) resp. Since
\( W_{1,RM} \) is convex in \( p \). As for \( W_{1,PC} \) we have:
with
The term \( A \) is always positive, while \( B > 0 \) iff \( m < \frac{{1 - c_{1} }}{{2{\kern 1pt} \theta_{0} }} \). Since \( 1 - c_{0} > 1 - c_{1} \), by (13) \( m > \frac{{1 - c_{0} }}{{2{\kern 1pt} \theta_{0} }} + v_{1} - v_{0} > \frac{{1 - c_{1} }}{{2{\kern 1pt} \theta_{0} }} \), thus \( B \) is always negative and \( W_{1,PC} \) is concave. Thus the difference \( W_{1,PC} - W_{1,RM} \) is concave. Since for \( p = v_{0} \) we have \( W_{1,PC} < W_{1,RM} \), while for \( p = v_{1} \) it is \( W_{1,PC} > W_{1,RM} \), it can be concluded that for \( p \in (v_{0} ,\;v_{1} ) \) a unique value \( p^{*} \) exists and such that for \( p < p^{*} \) the welfare level in RM is greater than in PC, while the contrary is true for \( p > p^{*} \).
The welfare difference for Region 1 between PC and NM is given by
As shown above, \( W_{1,PC} \) is concave. Also we have
which, since \( - \frac{{1 - c_{0} }}{{\theta_{0} }} + \frac{{1 - c_{1} }}{{\theta_{1} }} < 0 \), is negative if
and by (13) this condition is always verified. Thus we can conclude that \( W_{1,PC} \) is strictly decreasing. Since
is positive, it holds that \( W_{1,PC} > W_{1,NM} \) for all \( p \in \left[ {v_{0} ,\;v_{1} } \right] \).
Rights and permissions
Copyright information
© 2014 Springer-Verlag Italia
About this chapter
Cite this chapter
Levaggi, L., Levaggi, R. (2014). Patients’ Mobility Across Borders: A Welfare Analysis. In: Levaggi, R., Montefiori, M. (eds) Health Care Provision and Patient Mobility. Developments in Health Economics and Public Policy, vol 12. Springer, Milano. https://doi.org/10.1007/978-88-470-5480-6_8
Download citation
DOI: https://doi.org/10.1007/978-88-470-5480-6_8
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5479-0
Online ISBN: 978-88-470-5480-6
eBook Packages: Business and EconomicsEconomics and Finance (R0)